About
Company
History
Core Values
R&D Environment
Partners
Vision
Board of Directors
Our Team
New Facility Construction
Products & Technology
Products Overview
Pipeline
CRO & CDMO SERVICES
Equipments
Nuclear Medicine Applications
Quality Management
GMP Certification
Supplier Management
Tungsten Container Management App
News & Events
Latest News
Media Coverage
Investors
Corporate Governance
Public Information
Audit Committee
Remuneration Committee
Prevention of Insider Trading
Stakeholders
Dividend Policy
Financial Reports
Annual Reports
Investor Conferences
Investor Contact
Internal Audit System
Investor Relations Contact
Major Shareholders List
ESG
Environmental Policy
Sustainability Vision
Human Rights Commitment & Policy
Employee Welfare Policy
Workplace Safety & Health
Employee Training Program
Social Engagement
Contact Us
繁中
EN
繁中
News & Events
Home
／
News & Events
／
Latest News
／Received Taiwan FDA marketing approval for 131I capsule.
Navegation Button
Latest News
Media Coverage
Received Taiwan FDA marketing approval for 131I capsule.
2017-10-16
Prev
Back Page
Next
本網站使用Cookies
我們使用Cookies來了解您如何使用我們的網站並改善您的體驗，包括個性化內容，如繼續使用我們的網站，即表示您接受我們使用Cookies。
Agree
